Advertisement

Topics

Novo Nordisk, Inc. Company Profile

16:38 EDT 26th July 2017 | BioPortfolio

Novo Nordisk is a global healthcare company with more than 87 years of innovation and leadership in diabetes care. The company also has leading positions within hemophilia care, growth hormone therapy and hormone therapy for women. Novo Nordisk's business is driven by the Triple Bottom Line: a commitment to social responsibility to employees and customers, environmental soundness and economic success. Headquartered in Denmark, Novo Nordisk employs more than 29,650 employees in 76 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchange in Copenhagen and its ADRs are listed on the New York Stock Exchange (NVO). For more information, visit novonordisk-us.com.


News Articles [497 Associated News Articles listed on BioPortfolio]

Novo Nordisk A/S: Change in composition of the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 16 May 2017 - Novo Nordisk today announced that Mary Szela steps down from Novo Nordisk's board of directors with immediate effect. The decision follows changed strategic focus ...

Novo Nordisk: Sehen wir bald den Ausbruch? Trading-Chance voraus!

Unser Trade mit Novo Nordisk läuft schon seit dem 21. März, als wir im Express-Service eine Trading-Idee mit Novo Nordisk präsentiert hatten und dazu den Artikel dazu mit dem Titel: "Novo Nordisk: ...

Novo Nordisk-Aktie: Positiver Newsflow ebbt nicht ab!

Liebe Leser, mit den positiven Nachrichten rund um das Pharmaunternehmen Novo Nordisk geht es weiter. Durch die Empfehlung eines Ausschusses der US-Zulassungsbehörde FDA für das von Novo Nordisk en....

Novo Nordisk: Diese Entwicklung enthält eine klare Botschaft!

Lieber Leser, Novo Nordisk ist derzeit in schwacher Verfassung. Technische Analysten diagnostizieren einen Abwärtstrend, der noch weitergehen könnte. Denn Novo Nordisk hat zuletzt den GD200, der de....

Novo Nordisk: Wieder ein Treffer! Unsere Trading-Strategie ist Spitze!

Beim letzten Trade mit Novo Nordisk konnte man mehr als 50% Gewinn mitnehmen. Das hatten wir am 23. April melden können. Gleichzeitig haben wir den Artikel veröffentlicht: "Novo Nordisk: Sehen wir ....

Ypsomed-Aktien rücken dank guter Novo-Nordisk-Zahlen vor

Als Grund für die Kursavancen sehen Händler die am Morgen vom dänischen Insulinhersteller Novo Nordisk vorgelegten Quartalszahlen, die besser als erwartet ausgefallen sind. Ypsomed und Novo Nordisk...

Novo Nordisk A/S: Novo Nordisk receives US FDA approval of REBINYN® (nonacog beta pegol; N9-GP)

Bagsværd, Denmark, 31 May 2017 - Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved the Biologics License Application for REBINYN® for the treatment of adults.....

Novo Nordisk: Volltreffer + 70%! Auch dieser Trade funktioniert sehr gut!

Beim letzten Trade mit Novo Nordisk konnte man mehr als 50% Gewinn mitnehmen. Das hatten wir am 23. April melden können. Gleichzeitig haben wir den Artikel veröffentlicht: "Novo Nordisk: Sehen wir ....

Drugs and Medications [32 Associated Drugs and Medications listed on BioPortfolio]

Novolin [Novo Nordisk]

Novolin 70/30, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin)

Novolin [Novo Nordisk]

NOVOLIN N Human Insulin Isophane Suspension (recombinant DNA origin) 100 units/mL

Novolin [Novo Nordisk]

Novolin 70/30, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin)

Novolin [Physicians Total Care, Inc.]

Novolin 70/30, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin)

Novolin [Novo Nordisk]

R HUMAN Novolin R Regular, Human Insulin Injection (recombinant DNA origin) USP 100 units/mL

PubMed Articles [308 Associated PubMed Articles listed on BioPortfolio]

DIC in Decompensated Cirrhosis caused by Prothrombin Complex Concentrate and Recombinant Activated Factor VII: A Word of Caution.

We would like to respond to Scott et al. and the accompanying editorial.(1,2) Concentrated factor products like recombinant activated factor VII (NovoSeven(®) , Novo Nordisk Pharmaceuticals Inc.) an...

Terasaki epitope mismatch burden predicts the development of de novo DQ donor specific antibodies and are associated with adverse allograft outcomes.

De novo DQ DSA are associated with antibody-mediated rejection and allograft loss. Given the lack of effective treatment of de novo DQ DSA, their prevention is vital if there is to be an improvement o...

De Novo Cavernous Angioma Secondary to a Developmental Venous Anomaly:A Case Report and Review of the Literature.

Previously, cavernous angiomas(CAs)have been thought to be only congenital in origin. Recently, however, a few cases of de novo CAs have been reported in the literature. We present a case of a de novo...

De Novo Coding Variants Are Strongly Associated with Tourette Disorder.

Whole-exome sequencing (WES) and de novo variant detection have proven a powerful approach to gene discovery in complex neurodevelopmental disorders. We have completed WES of 325 Tourette disorder tri...

Refining the role of de novo protein-truncating variants in neurodevelopmental disorders by using population reference samples.

Recent research has uncovered an important role for de novo variation in neurodevelopmental disorders. Using aggregated data from 9,246 families with autism spectrum disorder, intellectual disability,...

Clinical Trials [309 Associated Clinical Trials listed on BioPortfolio]

Evaluation of the Effects of Different Interventions on Glycemic Control in Newly-Diagnosed Type 2 Diabetic Patients

The purpose of this study is to investigate and evaluate the effects of different interventions (1.continuous subcutaneous insulin infusion,2.multiple daily injections, 3.anti-hyperglycemi...

To Study Generic Estradiol 10 mcg Vaginal Tablets in the Treatment of Vulvar and Vaginal Atrophy in Post Menopausal Women.

This is a Randomized, Parallel-Group, Placebo- Controlled, Multicenter Study to Evaluate the Therapeutic Equivalence and Safety of Estradiol Vaginal Tablets 10 mcg and Vagifem® (Estradiol...

Evaluation of an Algorithm for Intensive s.c. Insulin Therapy in Emergency Room Patients With Hyperglycaemia

The aim of this study is to test the safety and efficacy of a new algorithm for intensive s.c. insulin injection in medical emergency patients with hyperglycaemia (plasma glucose concentra...

Comparison of 2 NovoFine® Needles on the Reflux of Insulin

This trial is conducted in Europe. This trial aims to ensure that there is no substantial clinically relevant difference between the two Novo Nordisk needles NovoFine® 6 x 0.30 mm and Nov...

Comparison of a Blood Clotting Drug (Recombinant Factor XIII) Produced by Two Different Manufacturers in Healthy Male Subjects

This trial is conducted in Europe. The aim of this clinical trial is to compare the metabolism of a blood-clotting drug (recombinant Factor XIII) produced by two different manufacturers (N...

Companies [51 Associated Companies listed on BioPortfolio]

Novo Nordisk, Inc.

Novo Nordisk is a global healthcare company with more than 87 years of innovation and leadership in diabetes care. The company also has leading positions within hemophilia care, growth hormone therapy...

Novo A/S

Novo A/S is fully owned by the Novo Nordisk Foundation and is the holding company of the Novo Group. Novo A/S is a private limited liability company and the majority shareholder in the publicly listed...

Novo Nordisk A/S

Novo A/S, the holding company of the Novo Group, is fully owned by the Novo Nordisk Foundation and was established to manage the Foundation's funds and to invest actively in other companies. What make...

Novo Nordisk

Novo Nordisk is a healthcare company and a world leader in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area ...

Novo Nordisk Inc.

More Information about "Novo Nordisk, Inc." on BioPortfolio

We have published hundreds of Novo Nordisk, Inc. news stories on BioPortfolio along with dozens of Novo Nordisk, Inc. Clinical Trials and PubMed Articles about Novo Nordisk, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Novo Nordisk, Inc. Companies in our database. You can also find out about relevant Novo Nordisk, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record